NexGel Inc Common Stock (NXGL)

About NXGL

NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments: Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications; and beauty and cosmetic solutions. It also develops NEXDrape…

Sector

Health Care

Industry

Medical/Dental Instruments

Employees

19

Website

nexgel.com/

Fundamentals

1-day range

$0.3338$0.3591

Market cap

$3.90M

P/E (trailing)

—

P/E (forward)

-1.60

EPS (trailing)

$-0.40

Dividend yield

—

Beta

0.74

Avg. volume

762.0K

Forecasts

1 analyst ratings

NexGel Inc Common Stock Competitors

Chosen by industry and closest market cap.

• NXGL

  NexGel Inc Common Stock

  $0.352

  ▲ 0.57%
  Market cap $3.90MP/E —
  $0.3001$2.89
• INBS

  Intelligent Bio Solutions Inc. Common Stock

  $2.36

  ▲ 3.96%
  Market cap $4.35MP/E —
  $1.52$24.9
• XAIR

  Beyond Air Inc. Common Stock

  $4.58

  ▼ 19.65%
  Market cap $4.56MP/E —
  $4.37$95.6
• TNON

  Tenon Medical Inc. Common Stock

  $5.22

  ▲ 3.98%
  Market cap $2.25MP/E —
  $4.38$50.4
• IVF

  INVO Fertility Inc. Common Stock

  $1.01

  ▼ 2.43%
  Market cap $2.24MP/E 0.00
  $0.9001$84.4
• VVOS

  Vivos Therapeutics Inc. Common Stock

  $0.2245

  ▼ 12.98%
  Market cap $5.84MP/E —
  $0.24$4.93
• AEMD

  Aethlon Medical Inc. Common Stock

  $2.47

  ▲ 13.82%
  Market cap $1.76MP/E —
  $2.17$105

P/E shows — for peers not currently carrying a live signal of their own.

Institutional Ownership

March 31, 2026

Total shares held

457.7K

Total value held

$279.4K

Institutional holders

17